Miriam Gargiulo
About
In The Last Decade
Miriam Gargiulo
19 papers receiving 333 citations
Peers
Comparison fields: 5 of 55
- Emergency Medicine 253
- Infectious Diseases 167
- Virology 124
- Cardiology and Cardiovascular Medicine 48
- Epidemiology 48
Countries citing papers authored by Miriam Gargiulo
This map shows the geographic impact of Miriam Gargiulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Gargiulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Gargiulo more than expected).
Fields of papers citing papers by Miriam Gargiulo
This network shows the impact of papers produced by Miriam Gargiulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Gargiulo. The network helps show where Miriam Gargiulo may publish in the future.
Co-authorship network of co-authors of Miriam Gargiulo
This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Gargiulo. A scholar is included among the top collaborators of Miriam Gargiulo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Gargiulo. Miriam Gargiulo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | Novel antiretroviral drugs and renal function monitoring of HIV patients. | 33 |
| 3 | Different impact of anti-retroviral regimen containing protease inhibitors on development of HIV-related Kaposi sarcoma. | 4 |
| 4 | Interferon gamma release assays and tubercolin skin test performance in different settings of HIV immunodeficiency. | 2 |
| 5 | 18 | |
| 6 | 9 | |
| 7 | Suppression of pre adipocyte differentiation and promotion of adipocyte death by anti-HIV drugs. | 7 |
| 8 | Comparative transcriptional profiling in HIV-infected patients using human stress arrays: clues to metabolic syndrome. | 7 |
| 9 | Safety of fosamprenavir in a cohort of HIV-1-infected patients with co-morbidities. | 2 |
| 10 | 19 | |
| 11 | [Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients]. | 4 |
| 12 | A color Doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1-positive patients. | 2 |
| 13 | 21 | |
| 14 | Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients. | 3 |
| 15 | 196 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 3 | |
| 19 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.